Pharmascience Inc. recalls one lot of prescription antifungal drug PMS-Nystatin Oral Suspension: Product may pose a choking risk

Summary Product: PMS-Nystatin Oral Suspension 100,000 units/mL (DIN 00792667), Lot 681044, Expires 30-11-2021. Issue: Product may contain clumps or jelly-like material, which may lead to choking. Newborns, infants and people with difficulty swallowing are particularly at risk. What to do: If, even after the product is shaken well, your product still contains clumps greater than 1 millimetre in size or jelly-like material, return it to your pharmacy for safe disposal and to obtain a replacement.

Reduce Health Costs By Nurturing The Sickest? A Much-Touted Idea Disappoints

Nearly a decade ago, Dr. Jeffrey Brenner and his Camden Coalition appeared to have an answer to remake American health care: Treat the sickest and most expensive patients. But a rigorous study in the New England Journal of Medicine shows the approach doesn’t save money. “We built a brilliant intervention to navigate people to nowhere,” Brenner tells the “Tradeoffs” podcast.